VSE knjižnice (vzajemna bibliografsko-kataložna baza podatkov COBIB.SI)
  • Etidronate does not suppress periprosthetic bone loss following cemented hip arthroplasty
    Fokter, Samo K. ...
    Periprosthetic bone loss after arthroplasty may threaten prosthesis survival. The current study investigated the effect of etidronate therapy on periprosthetic, contralateral hip, and spine bone ... mineral density (BMD) in a one-year, prospective, randomized, double-blind study on 46 patients after cemented hip arthroplasty. BMD was measured with dual-energy X-ray absorptiometry (DXA). There were no significant differences between mean BMD measurements of the etidronate and placebo groups, with the exception of the mean percent change in the spine at six months and 12 months and in Gruen zone3 at six monthsč in all three cases, the etidronate group had significantly greater mean values. These findings suggest that cyclic etidronate therapy has no significant effect in suppressing periprosthetic bone loss following cemented hip arthroplasty.
    Vir: International orthopaedics. - ISSN 0341-2695 (Vol. 29, no. 6, 2005, str. 362-367)
    Vrsta gradiva - članek, sestavni del
    Leto - 2005
    Jezik - angleški
    COBISS.SI-ID - 1890417

vir: International orthopaedics. - ISSN 0341-2695 (Vol. 29, no. 6, 2005, str. 362-367)
loading ...
loading ...
loading ...

Vnos na polico